Allyson Wehrheim
Medical · Vincennes, INNPI 1043705148
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations.
Across 199 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$493
- Novo Nordisk$467
- Amgen$277
- Lilly USA, LLC$234
- Inari Medical, Inc.$167
- GSK$149
- plus $1K from 33 others
What the payments were for
- Food & beverage$3,256100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $493 |
| Novo Nordisk | 32 | $467 |
| Amgen(2 entities) | 20 | $277 |
| Lilly USA, LLC | 15 | $234 |
| Inari Medical, Inc. | 2 | $167 |
| GSK | 10 | $149 |
| Mylan Specialty L.p. | 9 | $129 |
| Pfizer | 8 | $123 |
| Boehringer Ingelheim | 6 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $95 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $81 |
| Braintree Laboratories, Inc. | 4 | $73 |
| Merck | 5 | $71 |
| Viatris Specialty LLC | 4 | $66 |
| Ardelyx, Inc. | 4 | $65 |
| Bayer | 4 | $62 |
| Novartis | 3 | $58 |
| AstraZeneca | 4 | $54 |
| Verona Pharma, Inc. | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Abbott | 2 | $36 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Exact Sciences | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 2 | $25 |
| Eisai Inc. | 2 | $23 |
| Shield Therapeutics Inc | 1 | $19 |
| Biogen | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Corium, LLC | 1 | $16 |
| QOL Medical, LLC | 1 | $16 |
| Radius Health, Inc. | 1 | $16 |
| Stryker | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Inspire Medical Systems, Inc. | 1 | $13 |
| Boston Scientific | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Organon | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,256 in reported general payments places this provider in the 80th percentile of 273 medical providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $676 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $234 |
| Atorvastatin Calcium | 26 | $194 |
| Alprazolam | 15 | $91 |
| Amlodipine Besylate | 12 | $87 |
| Cephalexin | 11 | $87 |
| Triamcinolone Acetonide | 12 | $69 |
| Prednisone | 24 | $52 |
| Hydrochlorothiazide | 12 | $49 |
| Lisinopril | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Other medical in Vincennes
- Meggie BeckleyIndianapolis$125K
- Jennifer ConnerIndianapolis$98K
- Brandon BoydCarmel$46K
- Karey DavisNew Castle$45K
- Sheryl NewCarmel$39K
- Lindsey GradyValparaiso$39K
- Jennifer IrwinIndianapolis$34K
- Dennae DaltonZionsville$33K
- Jenifer FortneyFort Wayne$26K
- Jordan Stemer-MirandaCrown Point$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.